Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Observed in pilot human work A 2025 IV infusion pilot of BPC-157 in two adults at 10 mg and 20 mg reported no adverse effects on cardiac, hepatic, renal, thyroid, or glucose biomarkers (Lee et al., Alternative Therapies in Health and Medicine, 2025)
The evidence base is thinner than the popular discourse suggests
In recent years, peptide vaccination has been examined for various cancer subtypes
Stable gastric pentadecapeptide BPC 157-NO-system relation [PMID: 23755725] Laboratory literature summary: Stable gastric pentadecapeptide BPC 157-NO-system relation
Peptide therapy can be a useful tool in treating the underlying causes of IBD symptoms, from reducing inflammation to protecting your guts intestinal lining
The bottom line: BPC-157 is one of the most talked-about recovery peptides, and the early science is interesting
US$ 25.49
US$ 23.76
US$ 22.89
US$ 23.09
US$ 21.45
US$ 22.73
US$ 29.53
